Patient Experience of the Transition from Xalatan to Generic Latanoprost

Overview

Journal Eye (Lond)

Specialty Ophthalmology

Date 2014 Apr 12

PMID 24722506

Citations 6

Authors

S L Painter

A L Mead

Affiliations

Soon will be listed here.

Citing Articles

Generics versus brand-named drugs for glaucoma: the debate continues.

Bhartiya S, Dhingra D Rom J Ophthalmol. 2020; 64(3):239-244.

PMID: 33367157 PMC: 7739547.

The Use of Generic Medications for Glaucoma.

Tatham A J Ophthalmol. 2020; 2020:1651265.

PMID: 32322409 PMC: 7166283. DOI: 10.1155/2020/1651265.

Intraocular pressure with rebound tonometry and effects of topical intraocular pressure reducing medications in guinea pigs.

Di Y, Luo X, Qiao T, Lu N Int J Ophthalmol. 2017; 10(2):186-190.

PMID: 28251075 PMC: 5313539. DOI: 10.18240/ijo.2017.02.02.

Manchester iStent study: 3-year results and cost analysis.

Tan S, Au L Eye (Lond). 2016; 30(10):1365-1370.

PMID: 27391937 PMC: 5129859. DOI: 10.1038/eye.2016.139.

Reply to: 'Glaucoma prescribing trends in England 2000 to 2012'.

Tiew S, Choudhary A Eye (Lond). 2014; 29(1):147-8.

PMID: 25277301 PMC: 4289829. DOI: 10.1038/eye.2014.235.

References

Dubois V . Are generic topical prostanoids the way forward in the care of glaucoma patients? - No. Eye (Lond). 2013; 27(9):1002-3. PMC: 3772363. DOI: 10.1038/eye.2013.129. View

Titcomb L . Are generic topical prostanoids the way forward in the care of glaucoma patients? - Yes. Eye (Lond). 2013; 27(9):999-1001. PMC: 3772358. DOI: 10.1038/eye.2013.124. View